# Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines

> **NCT01432158** · PHASE3 · COMPLETED · sponsor: **University of Oxford** · enrollment: 4 (actual)

## Conditions studied

- Pneumococcal Disease

## Interventions

- **BIOLOGICAL:** Prevenar 13
- **BIOLOGICAL:** Pneumovax II

## Key facts

- **NCT ID:** NCT01432158
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-08
- **Final completion:** —
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2015-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01432158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01432158, "Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01432158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*